Document Detail

Hepatic Artery Reconstruction Prevents Ischemic Graft Injury, Inhibits Graft Rejection, and Mediates Long-term Graft Acceptance in Rat Liver Transplantation.
MedLine Citation:
PMID:  23769037     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND: Hepatic artery (HA) reconstruction is performed in the clinical liver transplantation.
METHODS: We assessed the importance of HA reconstruction in the success of liver transplantation. Orthotopic liver transplantation was performed without immunosspression from Lewis (RT1l) to Lewis rats (syngeneic transplantation) as well as Lewis to BN (RT1n) rats (allogeneic transplantation) with or without HA reconstruction. We examined graft function, pathology, and mRNA levels using DNA arrays in both arterialized and nonarterialized liver grafts.
RESULTS: In Lewis-to-Lewis syngeneic grafts, both the arterialized and nonarterialized grafts survived >120 days with normal graft function. lnfiltration of CD3(+) T cells and CD68(+) macrophages, marked bile duct proliferation with apoptotic epithelial cells, and expansion and increasing fibrosis of portal areas were evident in the nonarterialized grafts at day 120, although preservation of architecture was noted in the arterialized grafts. DNA array analysis of nonarterialized syngeneic grafts demonstrated the upregulation of mRNA of cell death-related proteins, cell cycle-related proteins, and inflammation-related proteins than those in arterialized grafts. Moreover, the arterialized Lewis-to-BN allogeneic grafts could survive for a long time with less severe graft dysfunction than those in non-arterialized allogeneic grafts.
CONCLUSIONS: HA reconstruction in liver transplantation inhibited hypoxic injury and subsequent inflammation and bile duct proliferation, prevented the augmentation of T-cell-and antibody-mediated rejection, and mediated long-term graft acceptance. HA reconstruction is essential factor in the success of liver transplantation.
E Ishii; A Shimizu; N Kuwahara; G Kanzaki; S Higo; Y Kajimoto; T Arai; S Nagasaka; Y Masuda; Y Fukuda
Related Documents :
23246477 - Carbon monoxide releasing molecules inhibit cell death resulting from renal transplanta...
24090807 - Peri-operative third party red blood cell transfusion in renal transplantation and the ...
23557127 - Interleukin receptor family member st2 concentrations in patients following heart trans...
24662167 - Uk renal registry 16th annual report: chapter 3 demographic and biochemistry profile of...
18816237 - A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosupp...
22483467 - Clinical outcomes of recipients with aplastic bone disease after renal transplantation.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Transplantation proceedings     Volume:  45     ISSN:  1873-2623     ISO Abbreviation:  Transplant. Proc.     Publication Date:  2013 Jun 
Date Detail:
Created Date:  2013-06-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0243532     Medline TA:  Transplant Proc     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1748-53     Citation Subset:  IM    
Copyright Information:
Copyright © 2013 Elsevier Inc. All rights reserved.
Department of Analytic Human Pathology, Nippon Medical School, Tokyo, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Chronic antibody-mediated responses may mediate chronic rejection in rat orthotopic liver transplant...
Next Document:  Acute Rejection After Swine Leukocyte Antigen-Matched Kidney Allo-Transplantation in Cloned Miniatur...